Abdominal normothermic regional perfusion in controlled DCD liver transplantation: outcomes and risk factors for graft loss

2021 ◽  
Author(s):  
Amelia J. Hessheimer ◽  
Gloria de la Rosa ◽  
Mikel Gastaca ◽  
Patricia Ruíz ◽  
Alejandra Otero ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Transplantation ◽  
Graft Loss ◽  
Regional Perfusion ◽  
Normothermic Regional Perfusion ◽  
Transplantation Outcomes

Surgical Site Infection After Liver Transplantation: Risk Factors and Association With Graft Loss or Death

2009 ◽  
Vol 87 (9) ◽  
pp. 1387-1393 ◽  
Author(s):  
Walter C. Hellinger ◽  
Julia E. Crook ◽  
Michael G. Heckman ◽  
Nancy N. Diehl ◽  
Jefree A. Shalev ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Transplantation ◽  
Surgical Site Infection ◽  
Graft Loss ◽  
Site Infection

Superior Outcomes Using Normothermic Regional Perfusion in CDCD Liver Transplantation

2018 ◽  
Vol 102 ◽  
pp. S380 ◽  
Author(s):  
Amelia Hessheimer ◽  
Elisabeth Coll ◽  
Andrés Valdivieso ◽  
Manuel Gómez ◽  
Julio Santoyo ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Regional Perfusion ◽  
Normothermic Regional Perfusion

Adherence to Posttransplantation Medical Regimen

2018 ◽  
Author(s):  
Lauren S Jones ◽  
Marina Serper
Keyword(s):  
Risk Factors ◽  
Liver Transplantation ◽  
Electronic Monitoring ◽  
Risk Groups ◽  
Current Evidence ◽  
Low Literacy ◽  
Improve Medication Adherence ◽  
Related Factors ◽  
Financial Barriers ◽  
Transplantation Outcomes

In this review, we provide an overview of the most current evidence on the prevalence, risk factors, and consequences of medication non-adherence (NA) in liver transplant recipients. Despite the improvement in long-term liver transplantation outcomes, medication NA is the leading cause of graft failure, graft rejection, and poor clinical outcomes. We examine methods of measuring NA as well as interventions that have been carried out to improve medication adherence and posttransplantation outcomes. Common risk factors for NA include low social support, medication-related factors (eg. side effects), regimen complexity, younger age, financial barriers, and low literacy. Additionally, we discuss special at-risk populations with pretransplantation substance abuse or psychiatric comorbidities as well as adolescents making a transition into adulthood and independent self-care. Multifaceted interventions that are personalized and specific to identified adherence barriers for high-risk groups seem to be the most promising approach to improve medication NA and posttransplantation outcomes. This review contains 4 figures, 5 tables, and 53 references Key Words: electronic monitoring, immunosuppression, liver transplantation, medication, nonadherence, noncompliance, tacrolimus standard deviation, transplantation outcomes

scholarly journals Pretransplantation risk factors for graft loss after liver transplantation in cirrhotic patients; effect of cytomegalovirus serologic status

2004 ◽  
Vol 17 (3) ◽  
pp. 131-137 ◽  
Author(s):  
Josep Maria Castellvi ◽  
Xavier Xiol ◽  
Jordi Guardiola ◽  
Isabel Sabate ◽  
Manuel Roca ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Transplantation ◽  
Graft Loss ◽  
Cirrhotic Patients

Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation

2019 ◽  
Vol 70 (4) ◽  
pp. 658-665 ◽  
Author(s):  
Amelia J. Hessheimer ◽  
Elisabeth Coll ◽  
Ferrán Torres ◽  
Patricia Ruíz ◽  
Mikel Gastaca ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Regional Perfusion ◽  
Rapid Recovery ◽  
Donation After Circulatory Death ◽  
Normothermic Regional Perfusion ◽  
Circulatory Death

scholarly journals Impact of Recipient and Donor Obesity Match on the Outcomes of Liver Transplantation: All Matches Are Not Perfect

2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Eliza W. Beal ◽  
Dmitry Tumin ◽  
Lanla F. Conteh ◽  
A. James Hanje ◽  
Anthony J. Michaels ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Graft Loss ◽  
Long Term Outcomes ◽  
Survival Curves ◽  
Liver Retransplantation ◽  
First Time ◽  
Transplantation Outcomes ◽  
Patient And Graft Survival ◽  
United Network

There is a paucity of literature examining recipient-donor obesity matching on liver transplantation outcomes. The United Network for Organ Sharing database was queried for first-time recipients of liver transplant whose age was ≥18 between January 2003 and September 2013. Outcomes including patient and graft survival at 30 days, 1 year, and 5 years and overall, liver retransplantation, and length of stay were compared between nonobese recipients receiving a graft from nonobese donors and obese recipient-obese donor, obese recipient-nonobese donor, and nonobese recipient-obese donor pairs. 51,556 LT recipients were identified, including 34,217 (66%) nonobese and 17,339 (34%) obese recipients. The proportions of patients receiving an allograft from an obese donor were 24% and 29%, respectively, among nonobese and obese recipients. Graft loss (HR: 1.27; 95% CI: 1.09–1.46;p=0.002) and mortality (HR: 1.38; 95% CI: 1.16–1.65;p<0.001) at 30 days were increased in the obese recipient-obese donor pair. However, 1-year graft (HR: 0.83; 95% CI: 0.74–0.93;p=0.002) and patient (HR: 0.84; 95% CI: 0.74–0.95;p=0.007) survival and overall patient (HR: 0.93; 95% CI: 0.86–1.00;p=0.042) survival were favorable. There is evidence of recipient and donor obesity disadvantage early, but survival curves demonstrate improved long-term outcomes. It is important to consider obesity in the donor-recipient match.

scholarly journals Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation

2017 ◽  
Vol 32 (2) ◽  
pp. e13163 ◽  
Author(s):  
Anne Claire den Dulk ◽  
Xiaolei Shi ◽  
Cornelia. J. Verhoeven ◽  
Jeroen Dubbeld ◽  
Frans H. J. Claas ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Transplantation ◽  
Graft Loss ◽  
Biliary Strictures ◽  
Hla Antibodies ◽  
Independent Risk Factors
Sign in / Sign up

Export Citation Format

Share Document